Drug Database
Back to search

Netherlands· NL-d24dcf2a3873

Dacarbazine medac 500 mg, poeder voor oplossing voor infusie

A dacarbazine product containing tridacarbazinecitraat, registered in Netherlands by Medac Gesellschaft für klinische Spezialpräparate mbH. The same ATC class is registered in 15 of our 19 countries.

ATC L01AX04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDacarbazine medac 500 mg, poeder voor…ATCL01AX04REGISTER NO.NL-d24dcf2a3873PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tridacarbazinecitraatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dacarbazine is registered in 15 of 19 countries.

Countries holding a registration under ATC L01AX04 (dacarbazine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search dacarbazine products by name

Dacarbazine · ATC L01AX04

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dacarbazine costs, country by country.

Normalised to the WHO defined daily dose (43.3 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Dacarbazine · price per daily dose (43.3 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$5.12
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TRIDACARBAZINECITRAAT
Manufacturer
Medac Gesellschaft für klinische Spezialpräparate mbH
Country
Netherlands (NL)
ATC code
L01AX04
ATC class
Dacarbazine
Defined daily dose
43.3 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    21714

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

237 interactions on record for dacarbazine.

Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dacarbazine against other medicinesHow interaction checks work

Dacarbazine · interactions on record

237 records

  • 35 severe
  • 114 moderate
  • 14 minor
  • 74 info

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • Nalidixic acidJ01MB02severe
  • CladribineL01BB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under L01AX04

Dacarbazine, as other registers publish it.

All dacarbazine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aeaa870d-11d6-4ba8-8acb-d2610e11e430
GET /v1/drugs/aeaa870d-11d6-4ba8-8acb-d2610e11e430?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h21714_smpc.pdf",
  "strength": null,
  "atc_label": "Dacarbazine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg21714",
  "excipients": [
    "CITROENZUUR 0-WATER (E 330)",
    "MANNITOL (D-) (E 421)"
  ],
  "substances": [
    "TRIDACARBAZINECITRAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h21714.pdf",
  "authorised_at": "1997/10/22",
  "procedure_number": "DE/H/0115/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "21714",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about dacarbazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console